NeuroTherapia Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$12.3M
- Investors
-
9
NeuroTherapia General Information
Description
Developer of cannabinoid receptor agonists designed to treat diseases associated with neuroinflammation. The company develops drugs that modulate microglial cell activity to reduce brain inflammation and neuronal injury, enabling pharmaceutical researchers and healthcare providers to explore potential treatments for Alzheimer's disease and neuropathic pain.
Contact Information
Website
www.neurotherapia.comCorporate Office
- PO Box 351
- 1500 Chagrin River Road
- Gates Mills, OH 44040
- United States
Corporate Office
- PO Box 351
- 1500 Chagrin River Road
- Gates Mills, OH 44040
- United States
NeuroTherapia Timeline
NeuroTherapia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 06-Aug-2024 | $12.3M | Completed | Clinical Trials - Phase 2 | ||
| 4. Later Stage VC (Series A) | 22-Sep-2020 | Completed | Clinical Trials - Phase 2 | |||
| 3. Grant | 21-Sep-2016 | Completed | Clinical Trials - Phase 2 | |||
| 2. Grant | 08-Sep-2026 | $2.3M | Completed | Clinical Trials - Phase 2 | ||
| 1. University Spin-Out | 13-Oct-2015 | $1M | Completed | Startup |
NeuroTherapia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A | 8,773,899 | $0.001000 | $0.05 | $1 | $1 | 1x | $1 | 35.29% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NeuroTherapia Comparisons
Industry
Financing
Details
NeuroTherapia Competitors (6)
One of NeuroTherapia’s 6 competitors is ADvantage Therapeutics, a Venture Capital-Backed company based in Miami, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ADvantage Therapeutics | Venture Capital-Backed | Miami, FL | ||||
| T3D Therapeutics | Venture Capital-Backed | Durham, NC | ||||
| Alector | Formerly VC-backed | South San Francisco, CA | ||||
| LeonaBio | Formerly VC-backed | Bothell, WA | ||||
| Verge Labs | Venture Capital-Backed | San Francisco, CA |
NeuroTherapia Patents
NeuroTherapia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024335816-A1 | Methods of treating cognitive impairment | Pending | 07-Sep-2023 | ||
| EP-4773962-A1 | Methods of treating cognitive impairment | Pending | 07-Sep-2023 | ||
| US-20250082624-A1 | Methods of treating cognitive impairment | Pending | 07-Sep-2023 | ||
| WO-2025054408-A1 | Methods of treating cognitive impairment | Inactive | 07-Sep-2023 | A61K31/4525 |
NeuroTherapia Signals
NeuroTherapia Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institute on Aging | Government | |||
| CRU Clinical Research Units | Corporation | Minority | ||
| Foundation For a Better World | Corporation | Minority | ||
| PMK-Group | Venture Capital | Minority | ||
| Alzheimer's Association | Corporation | Minority |
NeuroTherapia FAQs
-
When was NeuroTherapia founded?
NeuroTherapia was founded in 2015.
-
Where is NeuroTherapia headquartered?
NeuroTherapia is headquartered in Gates Mills, OH.
-
What is the size of NeuroTherapia?
NeuroTherapia has 3 total employees.
-
What industry is NeuroTherapia in?
NeuroTherapia’s primary industry is Drug Discovery.
-
Is NeuroTherapia a private or public company?
NeuroTherapia is a Private company.
-
What is the current valuation of NeuroTherapia?
The current valuation of NeuroTherapia is .
-
What is NeuroTherapia’s current revenue?
The current revenue for NeuroTherapia is .
-
How much funding has NeuroTherapia raised over time?
NeuroTherapia has raised $20.8M.
-
Who are NeuroTherapia’s investors?
National Institute on Aging, CRU Clinical Research Units, Foundation For a Better World, PMK-Group, and Alzheimer's Association are 5 of 9 investors who have invested in NeuroTherapia.
-
Who are NeuroTherapia’s competitors?
ADvantage Therapeutics, T3D Therapeutics, Alector, LeonaBio, and Verge Labs are some of the 6 competitors of NeuroTherapia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process